{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-241963","form_type":"8-K","ticker":"RANI","cik":"0001856725","company_name":"Rani Therapeutics Holdings, Inc.","filed_at":"2025-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.840561+00:00","generated_at":"2026-05-17T03:26:01.080970+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Rani raises $60.3M, partners with Chugai on hemophilia drug via RaniPill","bullets":["Private placement: ~$60.3M gross from 42.6M shares and warrants at $0.48/share (institutional) and $0.605 (affiliate).","Loan amendment: Avenue converts $6M debt into 12.5M shares and warrants on same PIPE terms.","Collaboration with Chugai: $10M upfront, up to $18M tech transfer, $57M development, $100M sales milestones, plus royalties.","Samsara and Anomaly get board appointment rights if each holds ≥25% of its PIPE securities.","Warrants exercisable five years post-stockholder approval; pre-funded warrants exercisable immediately."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-241963","json":"https://secwatch.observer/filing/0001193125-25-241963.json","markdown":"https://secwatch.observer/filing/0001193125-25-241963.md","text":"https://secwatch.observer/filing/0001193125-25-241963.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1856725/000119312525241963/0001193125-25-241963-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1856725/000119312525241963/d38236d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:26:01.080970+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}